Live life with more Time in Range1,
For people with Type 1 Diabetes
Real-time insulin adjustments and corrections for more Time in Range, day and night
Now available with:
Medtronic Extended Infusion set
The only infusion set that lasts for up to 7 days
NEW! Now available with:
Simplera™ Sync sensor
All-in-one, easy to apply sensor
Now available with:
Apple® Watch
Glucose alerts on your wrist
MiniMed™ 780G system with Simplera Sync™ sensor
Our most advanced insulin pump system with SmartGuard™ technology makes precise adjustments of insulin delivery to help prevent highs and lows — day and night.
Ever occasionally miss a meal dose or underestimate your carb count?
Life with diabetes can be unpredictable.
Only the MiniMed™ 780G system has a Meal Detection™ feature that can
I can just eat, maybe make a wrong calculation but it will fix it by
itself.
MiniMed™ 780G system user
SmartGuard™ technology
Automatically adjusts insulin delivery and corrects glucose levels every 5 minutes, 24/7 with 96% fewer injections and no finger pricks.
Anticipates
Predicts where your glucose levels are headed and how much insulin you'll need based on your real-time data and past
Adjusts
Makes precise adjustments of insulin delivery to help keep you in range and protect from highs and lows.
Corrects
Learn more about
the MiniMed™ 780G System
- Choudhary P. et al, Lancet Diabetes Endocrinol. 2022; https://doi.org/10.1016/ S2213-8587(22)00245-5
- Arrieta A, et al. Diabetes Obes Metab. 2022; doi: 10.1111/dom.14714. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- Carlson AL, et al. Diab Tech and Therap. 2021; DOI 10.1089/dia.2021.0319
- Collyns OJ, et al. Diabetes Care. 2021;44(4):969-975
- Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1,784 users using MiniMed™ 780G with recommended settings of 2 hours active insulin time nd 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
* Compared to MDI + isCGM
** Refer to System User Guide - SmartGuard™ feature. Some user interaction required
§ Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
^ The patients testimonials relates an account of an individual´s response to the treatment. The account is genuine, typical and documented. However, the individual´s response does not provide any indication, guide, warranty or guarantee as to the response other patients may have to the treatment. The response other patients have to the treatment could be different. Responses to the treatment discussed can and do vary and specific to the individual patient.
# Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. 1 with Medtronic Extended Infusion Set.
## Refer to MiniMed™ Mobile app. User Guide
¥ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
- 1.Choudhary P. et al, Lancet Diabetes Endocrinol. 2022; https://doi.org/10.1016/ S2213-8587(22)00245-5
- 2.Arrieta A, et al. Diabetes Obes Metab. 2022; doi: 10.1111/dom.14714. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- 3.Carlson AL, et al. Diab Tech and Therap. 2021; DOI 10.1089/dia.2021.0319
- 4.Collyns OJ, et al. Diabetes Care. 2021;44(4):969-975
- 5.Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1,784 users using MiniMed™ 780G with recommended settings of 2 hours active insulin time nd 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- * Compared to MDI + isCGM
- ** Refer to System User Guide - SmartGuard™ feature. Some user interaction required
- ** Refer to System User Guide - SmartGuard™ feature. Some user interaction required
- ¥ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
- § Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
- ^ The patients testimonials relates an account of an individual´s response to the treatment. The account is genuine, typical and documented. However, the individual´s response does not provide any indication, guide, warranty or guarantee as to the response other patients may have to the treatment. The response other patients have to the treatment could be different. Responses to the treatment discussed can and do vary and specific to the individual patient.
- # Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. 1 with Medtronic Extended Infusion Set.
- ## Refer to MiniMed™ Mobile app. User Guide
- ¥ A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required.
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, potential adverse events and any further information with your health care professional. Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to the therapy or products discussed. See the device manuals for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative.
UK-CGM-2400084© Medtronic 2024. All rights reserved. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. ™* Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMed™ 780G system algorithm includes technology developed by DreaMed Diabetes.